Mingfeng Liu

Mingfeng Liu

Auto-generated profile, based on publicly available information

Mingfeng Liu

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado 80303, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMingfeng Liu
Mingfeng Liu
ICIzabela Mamede Costa Andrade da Conceição
Izabela Mamede Costa Andrade da Conceição
SSSajad Sofi
Sajad Sofi
Isabela PereiraIsabela Pereira
Isabela Pereira
VDVishantie Dostal
Vishantie Dostal
JRJohn L. Rinn
John L. Rinn
Some long non-coding RNAs (lncRNAs) are known to regulate gene expression. However, the underlying temporal dynamics of lncRNAs influencing gene and epigenetic regulation and mechanisms of lncRNA regulation in trans are less understood. To investigate this, we genetically engineered 17 doxycycline-inducible lncRNA transgenes for ectopic expression at the H11 safe harbor locus in human pluripotent stem cells (hiPSCs), and we generated high-density temporal RNA-seq and ATAC-seq profiles. Most lncRNA transgenes were induced at 2 hours and maintained expression through the 96-hour time course. Surprisingly, when we sought to identify gene expression changes due to the lncRNAs, we found that the global transcriptional landscape was dominated by a strong systemic response triggered by doxycycline exposure. We rigorously defined this cohort of genes as a Doxycycline-Responsive Gene Signature (DRGS). The DRGS was also present in at least 28 public datasets from dox-inducible transgene studies involving diverse cell types. Next, we determined which lncRNAs exhibited trans-regulatory events. We identified DANCR, FENDRR, LINC00667, LINC00847, LNCPRESS1, and PNKY as lncRNAs that regulate specific transcript expression in trans. The downstream target genes encoded 53 mRNAs and 10 lncRNAs. None of the target lncRNAs altered gene expression proximal to their own loci (i.e., triggering secondary cis-effects). Surprisingly, the target genes of LINC00847 (transcribed from chromosome 22) were substantially enriched on chromosome 19, with a preponderance of target genes encoding RNA metabolism and RNA splicing factors. Collectively, our study provides a resource to discern artifacts in the doxycycline-inducible system and identifies temporally regulated targets of 6 lncRNAs for future mechanistic studies.

24 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
GWGuanhui Wu
Guanhui Wu
MLMingfeng Liu
Mingfeng Liu
AZArthur J. Zaug
Arthur J. Zaug
JRJohn L. Rinn
John L. Rinn
TCThomas R. Cech
Thomas R. Cech
Regulator of Telomere Elongation Helicase 1 (RTEL1) plays a critical role in telomere replication by disassembling DNA secondary structures such as G-quadruplexes and telomeric loops (T-loops). However, its precise mechanism remains unclear. Previously, we generated HeLa cells homozygous for ATPase-dead RTEL1 . Here, we found that these cells have a 50-77% reduction in the synthesis of both telomere strands, indicating that RTEL1 ATPase activity is important for both leading-strand and lagging-strand synthesis. Surprisingly, these cells also showed a substantial reduction in Telomerase Reverse Transcriptase (TERT) mRNA levels and an approximately 80% reduction in telomerase activity, without activating alternative lengthening of telomeres (ALT). Forced TERT overexpression suppressed proliferation and caused late S/G2 accumulation, implying that the naturally occurring reduction in TERT provides an adaptive mechanism for cell survival. Expressing the longest RTEL1 isoform at close to physiological levels failed to rescue growth defects, suggesting other isoforms are important for cell survival. These results reveal an unexpected interplay between RTEL1 and telomerase and show how cancer cells compensate for RTEL1 dysfunction by decreasing TERT expression. Graphical

9 October 2026 in Genome Research
Verified
Journal Article
Closed access
PDF file
MLMingfeng Liu
Mingfeng Liu
ICIzabela Mamede Costa Andrade da Conceição
Izabela Mamede Costa Andrade da Conceição
SSSajad Sofi
Sajad Sofi
Isabela PereiraIsabela Pereira
Isabela Pereira
VDVishantie Dostal
Vishantie Dostal
JRJohn L. Rinn
John L. Rinn
Some long noncoding RNAs (lncRNAs) are known to regulate gene expression. However, the underlying temporal dynamics of lncRNAs influencing gene and epigenetic regulation, as well as mechanisms of lncRNA regulation in trans , are less understood. To investigate this, we genetically engineer 17 doxycycline-inducible lncRNA transgenes for ectopic expression at the H11 safe harbor locus in human pluripotent stem cells (hiPSCs), and we generate high-density temporal RNA-seq and ATAC-seq profiles. Most lncRNA transgenes are induced at 2 h and maintain expression through the 96 h time course. Surprisingly, when we seek to identify gene expression changes owing to the lncRNAs, we find that the global transcriptional landscape is dominated by a strong systemic response triggered by doxycycline exposure. We rigorously define this cohort of genes as a doxycycline-responsive gene signature (DRGS). The DRGS is also present in at least 28 public data sets from dox-inducible transgene studies involving diverse cell types. Next, we determine which lncRNAs exhibit trans -regulatory events. We identify DANCR , FENDRR , LINC00667 , LINC00847 , LNCPRESS1 , and LNCPNKY as lncRNAs that regulate specific transcript expression in trans . The downstream target genes encode 53 mRNAs and 10 lncRNAs. None of the target lncRNAs alter gene expression proximal to their own loci (i.e., triggering secondary cis -effects). Surprisingly, the target genes of LINC00847 (transcribed from Chromosome 22) are substantially enriched on Chromosome 19, with a preponderance of target genes encoding RNA metabolism and RNA splicing factors. Collectively, our study provides a resource to discern artifacts in the doxycycline-inducible system and identifies temporally regulated targets of six lncRNAs for future mechanistic studies.